Orange Book product
AMLODIPINE AND OLMESARTAN MEDOXOMIL EQ 5MG BASE;40MG
Orange Book ANDA 091154 · TEVA PHARMACEUTICALS USA · Discontinued
Key facts
| Proprietary name | AMLODIPINE AND OLMESARTAN MEDOXOMIL |
|---|---|
| Active ingredients | AMLODIPINE BESYLATE, OLMESARTAN MEDOXOMIL |
| Strength | EQ 5MG BASE;40MG |
| Dosage form | TABLET |
| Route | ORAL |
| Application | ANDA091154 |
| Applicant holder | TEVA PHARMACEUTICALS USA |
| Marketing status | Discontinued |
| Reference listed drug (RLD) | No |
| Reference standard (RS) | No |
| Approval date | Oct 26, 2016 |
At a glance
- 10–99 Marketed products with the same ingredient, strength and form
- 1–9 Products in this application
- No Reference listed drug
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Orange Book products
The FDA Orange Book lists approved drug products with their therapeutic equivalence (TE) codes, reference listed drugs and marketing status. Products approved before 1982 show an approval date of Jan 1, 1982.